ofloxacin has been researched along with Arthritis, Rheumatoid in 3 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a 6-month, double-blind trial, we randomly assigned 76 patients with persistently active rheumatoid arthritis despite at least 6 months of methotrexate therapy at a stable dose of 15 to 25 mg per week to receive either levofloxacin (500 mg) or placebo orally once daily while continuing to receive methotrexate." | 9.12 | Levofloxacin treatment in patients with rheumatoid arthritis receiving methotrexate. ( Ogrendik, M, 2007) |
| "In a 6-month, double-blind trial, we randomly assigned 76 patients with persistently active rheumatoid arthritis despite at least 6 months of methotrexate therapy at a stable dose of 15 to 25 mg per week to receive either levofloxacin (500 mg) or placebo orally once daily while continuing to receive methotrexate." | 5.12 | Levofloxacin treatment in patients with rheumatoid arthritis receiving methotrexate. ( Ogrendik, M, 2007) |
| "We report the antiinflammatory effect and efficacy of preoperative treatment with ketorolac in a patient with rheumatoid arthritis having phacoemulsification." | 3.71 | Antiinflammatory effect of preoperative ketorolac in phacoemulsification. ( Caronia, RM; Donnenfeld, ED; Perry, HD, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, HW | 1 |
| Lai, CC | 1 |
| Tan, CK | 1 |
| Caronia, RM | 1 |
| Perry, HD | 1 |
| Donnenfeld, ED | 1 |
| Ogrendik, M | 1 |
1 trial available for ofloxacin and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Levofloxacin treatment in patients with rheumatoid arthritis receiving methotrexate.
Topics: Anti-Bacterial Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Double-Blind Method; Drug Therap | 2007 |
2 other studies available for ofloxacin and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Arthritis caused by Mycobacterium terrae in a patient with rheumatoid arthritis.
Topics: Adult; Anti-Bacterial Agents; Arthritis, Rheumatoid; Azithromycin; Drug Therapy, Combination; Ethamb | 2009 |
Antiinflammatory effect of preoperative ketorolac in phacoemulsification.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cataract; Drug Therapy, Combin | 2002 |